A Study to Compare Different Intubating Doses of Zemuron in Pediatric and Adolescent Subjects Under General Anesthesia
Status:
Completed
Trial end date:
2007-07-01
Target enrollment:
Participant gender:
Summary
The primary purpose of this study is to evaluate the time course of muscle relaxation after
administration of three different single intravenous bolus doses of rocuronium bromide for
intubation (insertion of a tube through the nose or mouth into the trachea to provide
artificial ventilation) in term neonates (birth to <28 days old), infants (28 days to <=3
months) and toddlers (>3 months to <=2 years), children (2 years to less than or equal to 11
years of age), and adolescents (>11 years to less than or equal to 17 years of age).
Subjects in each of the age groups will be randomized to one of 3 Zemuron® doses: 0.45 mg/kg,
0.6 mg/kg, or 1.0 mg/kg.